Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

The Lancet ◽  
1994 ◽  
Vol 344 (8930) ◽  
pp. 1105-1110 ◽  
Author(s):  
M.J Elliott ◽  
R.N Maini ◽  
M Feldmann ◽  
J.R Kalden ◽  
C Antoni ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Α ◽  
Double Blind ◽  
Chimeric Monoclonal Antibody ◽  
Blind Comparison ◽  
Factor Α ◽  
Necrosis Factor

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

The Lancet ◽  
1994 ◽  
Vol 344 (8930) ◽  
pp. 1125-1127 ◽  
Author(s):  
M.J. Elliott ◽  
R.N. Maini ◽  
M. Feldmann ◽  
A. Long-Fox ◽  
P. Charles ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibody ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Α ◽  
Factor Α ◽  
Necrosis Factor

scholarly journals Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

2015 ◽  
Vol 75 (10) ◽  
pp. 1757-1762 ◽  
Author(s):  
Theresa Wampler Muskardin ◽  
Priyanka Vashisht ◽  
Jessica M Dorschner ◽  
Mark A Jensen ◽  
Beverly S Chrabot ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Α ◽  
Factor Α ◽  
Pretreatment Serum ◽  
Necrosis Factor

scholarly journals Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
N. R. Bonetti ◽  
C. Diaz-Cañestro ◽  
L. Liberale ◽  
M. Crucet ◽  
A. Akhmedov ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Mouse Model ◽  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Stroke Outcome ◽  
Tumour Necrosis Factor Α ◽  
Factor Α ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document